VC  Agent Capital

     Office Locations:

810 Memorial Drive, Mezzanine Floor, Suite 107
Cambridge, MA 02139
Phone: 844-691-6233



  • Early
  • Expansion
  • Seed



  • Life Sciences & Healthcare



    Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. The firm maintains a balanced two-pronged approach, between clinical stage companies with high commercial potential and early-stage transformative technologies prime for future M&A. The firm makes direct equity investments across all stages of clinical development in Therapeutic Areas such as: Rare diseases, Oncology, Neurology / CNS, and Immunology.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Geeta Vermuri Managing Partner
    Marta New Partner
    Preston Noon Principal


    Recent Funding Events (trailing 12 months):







      Entrada Therapeutics



      Series A


      Pliant Therapeutics



      Series B


      Verge Genomics



      Series A


      Carisma Therapeutics



      Series A


    Portfolio companies include:

        web link

      Carisma Therapeutics
        web link

      Entrada Therapeutics
        web link

      Orbus Therapeutics

      Orchard Therapeutics
        web link

      Palvella Therapeutics

      Pliant Therapeutics
        web link

      Verge Genomics
        web link


    Recent News: